Diaston

Quick links to important sections

Diaston

Method of action: Antidiarrheal, Obstructive

Treatment option: Irritable Bowel Syndrome

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diaston

Quick Facts About Diaston

Property Description
Active Ingredient Loperamide hydrochloride
Form Oral preparations (tablets, capsules, solution)
Pharmacological Class Antidiarrheal agent
Common Purpose Symptomatic relief of diarrhea
Origin Synthetic opioid derivative

What Pharmacological Class Does Diaston Belong To?

Diaston is a synthetic medicinal product whose active component is Loperamide hydrochloride. It is categorized as an antidiarrheal agent and specifically as a gastrointestinal motility inhibitor. The medicine is a phenylpiperidine derivative designed to act as a peripheral mu-opioid receptor agonist within the intestinal wall. This targeted action is clinically recognized for delivering effective control over gastrointestinal transit without the significant central effects associated with some older opioid-derived compounds.


Composition and Forms of Diaston

Diaston is a single-ingredient product, containing only Loperamide hydrochloride as the therapeutic agent, combined with pharmaceutical excipients necessary for stability and structure. It is typically classified as an Over-The-Counter (OTC) medicine in its lower strengths and is manufactured for oral administration in common dosage forms such as tablets and capsules. Loperamide is used to reduce the volume of fluid and electrolytes lost via the gastrointestinal tract.


What is the General Purpose of Diaston?

The general purpose of Diaston is the symptomatic relief of diarrhea. It achieves this by directly inhibiting rapid propulsive peristalsis, thereby decreasing the frequency of bowel movements and the urgency associated with acute diarrhea. This action provides an extended duration for the intestinal lining to reabsorb water and electrolytes, which helps restore firmer stool consistency. This mechanism assists in managing the fluid loss and discomfort that often accompanies acute, non-specific diarrhea.

What side effects are possible with Diaston?

Possible Side Effects and Safety Information

The safety profile of Diaston (diazepam rectal gel) is primarily characterized by effects on the Central Nervous System (CNS), reflecting its formal classification as a CNS depressant in regulatory documents. Adverse reactions are grouped by the physiological system affected and classified by frequency based on clinical trial data.


Frequency-Classified Adverse Reactions

The most frequently reported effects, as documented in FDA labeling, include:

  • Very Common (≥10%): Somnolence (Drowsiness/Sleepiness).
  • Common (1% to 10%): Headache, Dizziness, Ataxia (Lack of Coordination), Diarrhea, Euphoria, Vasodilatation, Rash, and Asthma.

These effects often involve the Nervous System Disorders and tend to be transient, being more prominent at the start of treatment. Gastrointestinal and Skin and Subcutaneous Tissue disorders are also included in the official listings.


Serious Safety Concerns and Restrictions

Official regulatory documents include a Boxed Warning highlighting serious risks. These include the potential for Profound Sedation, Respiratory Depression, Coma, and Death, especially when Diaston is used concomitantly with opioids. The potential for Abuse, Misuse, and Addiction, as well as the risk of Dependence and acute Withdrawal Reactions, is also explicitly documented, emphasizing that these risks increase with longer duration or more frequent use than indicated.

Use is formally restricted by contraindications, including specific pre-existing conditions such as Severe Hepatic Insufficiency, Myasthenia gravis, and Severe respiratory insufficiency. The safety profile also includes specific considerations for older adults due to prolonged clearance and is restricted to patients 2 years of age and older.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose of Diaston (diazepam rectal gel) is characterized by manifestations of severe Central Nervous System (CNS) depression. Documented clinical signs include profound sedation, confusion, diminished reflexes, and lack of coordination (ataxia). Severe presentations can rapidly escalate to respiratory depression and coma. The official regulatory labeling notes that the risk of life-threatening outcomes, including death and cardiac arrest, is significantly increased when Diaston is used with other CNS depressants, particularly opioids.

If an overdose is suspected, immediate medical attention must be sought. Emergency services should be contacted immediately if the individual collapses, experiences trouble breathing, or cannot be awakened.

Official regulatory documents specify that management is focused on symptomatic and supportive treatment. This includes maintaining a patent airway, continuous monitoring of vital signs, and, potentially, the use of activated charcoal. The specific antidote, Flumazenil, may be administered by healthcare professionals, though regulatory information cautions that this may precipitate acute withdrawal reactions. Population-specific considerations note that effects can be prolonged in elderly patients and those with hepatic or renal impairment.

Therapeutic Uses of Diaston

Therapeutic Uses of Diaston

Diaston (diazepam rectal gel) is approved for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity. This is specifically for events like seizure clusters or acute repetitive seizures that differ from a patient’s ordinary seizure pattern. The medication is used in refractory patients with epilepsy who are already on stable regimens of antiepileptic drugs (AEDs) and require intermittent, emergency use of diazepam to control these bouts of increased seizure activity. It is intended for use in patients 2 years of age and older.

Therapeutic Benefit

  • Seizure Management: The primary benefit of Diaston is to suppress seizures by interacting with gamma-aminobutyric acid (GABA) receptors in the central nervous system. This action enhances the natural inhibitory effects of GABA, which helps reduce the excessive depolarization of neurons implicated in seizure generation and spread. The medication is effective in providing rapid control of these acute, repetitive seizure episodes.
  • Intermittent Use: It is specifically indicated for intermittent use, providing an important acute management option for caregivers to address episodes of increased seizure frequency in a timely manner. This management strategy can help prevent the potential risks associated with prolonged seizure activity.

Eligibility and Restrictions for Use

Who Can and Cannot Use Diaston (Diazepam Rectal Gel)

Official regulatory documents define specific patient populations eligible for Diaston and those for whom use is strictly contraindicated or restricted. The medicine is formally indicated for use in patients 2 years of age and older for the acute management of specific seizure episodes.


Contraindications and Age Limitations

Use is contraindicated in any patient with a known hypersensitivity to diazepam or who has acute narrow angle glaucoma. The safety and effectiveness of the medicine have not been established in children younger than 2 years of age, and use is generally not recommended in infants under 6 months.


Condition-Based and Life Stage Restrictions

Use is not recommended during breastfeeding, as the drug is excreted in human milk, and it is generally avoided during pregnancy. Special caution is required for elderly patients, who may be more susceptible to adverse effects. Restrictions also apply to individuals with hepatic impairment (liver disease) or those with severe respiratory insufficiency, as use may be conditionally limited due to altered drug clearance or potential condition exacerbation. Caution is also necessary for patients with a history of alcohol or drug abuse.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Diaston (diazepam rectal gel) documents clinically significant interactions across several categories.

A major restriction, highlighted by a regulatory Boxed Warning, concerns the co-administration of Diaston with Opioids. This combination carries a documented risk of profound sedation, respiratory depression, coma, and death. Diaston is also formally contraindicated in patients diagnosed with Acute Narrow Angle Glaucoma.


Pharmacokinetic and Pharmacodynamic Interactions

The pharmacokinetics of Diaston are significantly affected by substances that modulate the CYP2C19 and CYP3A4 enzymes. Inhibitors of these enzymes, such as Cimetidine and Ketoconazole, decrease the rate of drug elimination, which can increase plasma concentrations. Conversely, inducers like Phenytoin and Carbamazepine increase the rate of drug elimination, which may lead to reduced drug exposure.

Pharmacodynamic interactions occur with other Central Nervous System (CNS) Depressants, resulting in an additive or synergistic CNS-depressant effect.


Substance and Population Considerations

Interactions with other substances are also documented: Alcohol (Ethanol) poses a risk of synergistic CNS depression, while the herbal product St. John's Wort and Grapefruit Juice may also affect the product’s profile. In the population with hepatic impairment, the drug's clearance is officially documented to be decreased by half, resulting in a prolonged drug half-life.

Mechanism of Action

How Diaston Works

Diaston (Loperamide) operates through the modulation of two physiological processes confined to the gastrointestinal tract: motility and fluid transport. The mechanism is highly peripheral.

Molecular Mechanism: Peripheral mu-Opioid Receptor Agonism

Loperamide functions as a targeted agonist of the mu-opioid receptors (MOR), which are concentrated on nerve cells within the intestinal wall's myenteric plexus. This receptor activation results in the presynaptic inhibition of excitatory signaling molecules, specifically acetylcholine and prostaglandins, which stimulate gut movement and secretion.

Physiological Consequence: Modulating Transit Time and Secretion

The inhibition of excitatory signaling causes a functional reduction in propulsive peristalsis (the speed of intestinal transit) and a decrease in intestinal secretion. By slowing the movement of contents and limiting fluid loss into the lumen, the mechanism provides an extended window for the intestinal mucosa to facilitate the reabsorption of water and electrolytes. This physiological adjustment determines the functional alteration in intestinal output.

Selectivity Mechanism: P-Glycoprotein-Mediated Efflux

The peripheral constraint of the mechanism is maintained by its interaction with the P-glycoprotein (P-gp) efflux transporter, a major component of the Blood-Brain Barrier. This active transport mechanism functionally restricts the drug's activity to the peripheral mu-opioid receptors in the gut, limiting access to central nervous system pathways.

Dosage and Administration Information

Diaston (diazepam rectal gel) is administered exclusively via the rectal route using a prefilled unit-dose syringe for the acute management of intermittent, repetitive seizure episodes. Its use is strictly event-driven and limited; it is not indicated for daily, chronic anticonvulsant therapy.


Official Dosing and Scheduling

The prescribed dose is weight-based and determined by the patient's age category, ranging from 0.5 mg/kg for younger children to 0.2 mg/kg for patients 12 years and older. The calculated dose is always rounded upward to the nearest available unit-dose size, up to a maximum single dose of 20 mg.

Regarding frequency, Diaston is approved for a maximum of two doses per seizure episode, with the optional second dose administered 4 to 12 hours after the initial dose. Overall use is limited to no more than five episodes per month, with a minimum interval of five days between treatment courses.


Administration Procedure and Context

Administration must be performed by a trained caregiver in a non-clinical setting, such as a home. The procedure involves lubricating the syringe tip and then gently inserting it into the rectum, followed by holding the patient’s buttocks together for a brief count to ensure proper retention of the dose. Diaston is indicated for use in patients 2 years of age and older, and dose adjustments are generally recommended for older or debilitated individuals.


Connection to the overall use protocol: The protocol establishes Diaston as a highly controlled, event-driven therapy. This structure mandates precision in dosing via weight-based calculations and strict limits on frequency to ensure the medicine is only used for the intended acute management episodes.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Diaston

The research evidence for Diaston (Diazepam Rectal Gel) is focused on its evaluation for use during acute seizure episodes. Studies used for regulatory review are designed to see how symptoms change over time during these periods of heightened seizure activity, according to official governmental and peer-reviewed sources.


Evidence for Acute Treatment of Seizure Clusters

Research for the evaluation of intermittent, stereotypic episodes of frequent seizure activity, sometimes called seizure clusters or acute repetitive seizures, includes multiple randomized, double-blind, placebo-controlled trials (RCTs). These controlled trials are foundational to the evidence base.

Studies examined measurements of the time elapsed before the next seizure occurred across the study and placebo groups. Research examined outcomes related to being seizure-free during the acute, short-term observation window (typically 12 hours). Studies monitored patient-reported outcomes describing perceived discomfort and observed patterns in how symptoms evolved in the populations studied.

Study Design and Measured Outcomes

The main research examined outcomes describing episodic or acute changes in seizure activity. Researchers measured endpoints such as the specific duration of time that elapsed from the intervention until the next seizure event. They also applied in studies examining patient-reported experiences through questionnaires, where caregivers provided a global assessment of the medicine's action during the acute episode.


Long-Term and Intermittent Use Follow-up

While the initial, rigorous RCTs focused on evaluating short-term changes during acute episodes, open-label studies have been used to monitor the experiences of individuals using Diaston intermittently over longer observation periods, extending up to two years. Research has explored outcomes reflecting daily functioning and how participants experienced repeated administration during periods of recurrent clusters.

Long-term outcomes related to the overall seizure condition are not fully established. Follow-up durations were limited in terms of assessing the impact of the medication over multiple years, meaning there is limited information for long-term outcomes beyond tolerance and safety patterns.


What Remains Uncertain and Research Gaps

Scientific reviews classify the evidence base used to evaluate Diaston for its approved indication as having a High level of certainty for acute use. However, certain aspects remain uncertain. Comparative evidence is lacking regarding how this formulation was evaluated against some newer acute rescue treatments. Furthermore, the societal or practical barriers to the rectal route were observed in some studies as a potential research limitation, which may affect the generalizability of the findings.

Key Studies & References Long-Term Safety and Tolerability of Intermittent Use of Rectal Diazepam for Acute Repetitive Seizures in Pediatric and Adult Patients

Frequently Asked Questions (FAQ)

Common questions about Diaston (FAQ)


Q: How quickly does Diaston start to work?

A: Diaston is indicated for the acute management of seizure episodes. Official pharmacokinetic information indicates that the drug is quickly taken into the body, with peak amounts in the bloodstream typically reached about 1.5 hours after administration. Reported effects on the central nervous system may be noted within 5 to 30 minutes following administration.


Q: What is the difference between Diaston and [Name of Similar Drug]?

A: Diaston is a specific medicine containing the active ingredient diazepam. It is uniquely formulated as a rectal gel delivery system, which allows it to be used for the immediate, intermittent management of seizure episodes outside of a hospital or clinic. This specific formulation is intended to provide rescue treatment when administered by a trained caregiver.


Q: What happens if I take too much Diaston?

A: The administration of doses higher than those approved may result in signs of an overdose. Official drug labeling lists symptoms that may include severe sleepiness, confusion, problems with coordination, slow reflexes, and in the most serious cases, coma. An overdose is associated with the risk of profound breathing problems.


Q: What is the typical timeframe to see the full effect of Diaston?

A: Diaston is indicated for the acute, intermittent management of seizure episodes. Clinical studies that examined its use for seizure clusters typically monitored the duration of seizure freedom for up to 12 to 24 hours after the dose. The drug peaks in the blood about 1.5 hours after dosing, and common temporary side effects like unsteadiness or poor coordination may be reported to dissipate within about four hours.


Q: Is Diaston a controlled substance?

A: Yes, regulatory documents confirm that Diaston, which contains diazepam, is classified as a Schedule IV controlled substance in the United States. This classification reflects the drug's approved medical use but also acknowledges its potential for abuse and dependence.


Q: Is Diaston addictive?

A: Official regulatory warnings note that the use of Diaston, like other medicines in its class (benzodiazepines), carries risks including abuse, misuse, addiction, physical dependence, and withdrawal reactions. These risks are described as increasing with use that is more frequent or of longer duration than officially indicated.


Q: Are there any long-term health risks associated with Diaston use?

A: Diaston is indicated for short-term, intermittent use only. While it is not designed for chronic daily use, regulatory documents warn that risks such as dependence and withdrawal increase if it is used more frequently or for longer periods than recommended. Official documents recommend special caution for older patients, and prolonged use in this population is generally restricted.


Q: Can I stop taking Diaston suddenly?

A: Because Diaston is only prescribed for intermittent, as-needed use, abrupt discontinuation is typically not a concern for most users. However, if the medicine is used more often or for a longer duration than indicated, rapid stopping may cause acute withdrawal reactions, and gradual management of the dose is often required.


Q: How is Diaston eliminated from the body?

A: Official information indicates that Diaston is broken down extensively by specific enzymes in the liver. After metabolism, the drug and its active parts are mostly eliminated from the body through urine. This process is important for understanding how long the drug's effects may last.


Q: Is Diaston the same as other medications used for the same condition?

A: Diaston's active ingredient, diazepam, is part of a class of medicines called benzodiazepines, which share a common mechanism of action by working on GABA-A receptors. This mechanism is similar to that of other drugs used to stop acute seizures, but Diaston is distinct because of its specific rectal gel formulation and indication for acute, rescue use.


Q: Do I need to take Diaston long-term?

A: No, Diaston is specifically approved as a short-term, intermittent rescue treatment for acute seizure episodes. It is not intended for use as a daily, long-term medication to prevent seizures and is limited to a maximum of five episodes treated per month.


Q: Is it normal to feel [specific vague feeling like dizzy or tired] when starting Diaston?

A: The official safety data lists drowsiness (somnolence) as the most commonly reported side effect. Other common central nervous system effects include dizziness and a lack of coordination. Regulatory information indicates that these effects are often temporary and may be more noticeable when the medicine is first administered.


Q: Are there any major food restrictions while using Diaston?

A: Since Diaston is administered rectally, it bypasses the normal digestive process, so there are no general food restrictions. However, official drug interaction data notes that consuming grapefruit juice may affect the way the drug is processed in the body.


Q: Is it safe to drink alcohol while taking Diaston?

A: Official regulatory warnings document that co-administering alcohol (ethanol) with Diaston is strongly discouraged. Combining them can increase the risk of severe side effects because both are Central Nervous System (CNS) depressants, which can lead to excessive drowsiness and significant breathing difficulties.


Q: Why do some people stop taking Diaston?

A: Regulatory information indicates that the reasons for treatment discontinuation in studies are often related to the reported side effects. These include issues like drowsiness, a lack of coordination, or the potential for tolerance and dependence in people who may use the medicine more often than indicated.


Q: What if I have an allergic reaction to Diaston?

A: Diaston is strictly contraindicated (must not be used) in anyone with a known hypersensitivity or allergy to the drug. Signs of a serious allergic reaction, such as difficulty breathing or swelling of the face, lips, tongue, or throat, are considered a medical emergency.


Q: Does Diaston cause changes in mood or behavior?

A: Official safety documents list the occurrence of euphoria (an unusual 'high' feeling) as a reported adverse effect. Other changes, such as excitement or nervousness, have also been noted. In general, a class-wide warning for all anti-seizure medications concerns the potential for changes in mood, behavior, and suicidal ideation.


Q: Can Diaston be crushed or split?

A: Diaston is not supplied as a tablet or capsule that can be crushed or split. It is provided only as a rectal gel pre-filled in a unit-dose syringe for administration by a trained caregiver.


Q: Are there different strengths of Diaston tablets?

A: Diaston is not available in tablet form. It is supplied as a rectal gel in pre-filled, single-use syringes. The pre-filled syringes are supplied in various doses.


Q: Does taking Diaston at a certain time of day make a difference?

A: The official use of Diaston is strictly event-driven. The medicine is only administered in response to an acute, repetitive seizure episode, not on a routine, scheduled basis, such as morning or night.


Q: Is the Diaston dose adjusted for people with liver problems?

A: Official information indicates that the drug’s elimination time is significantly prolonged in patients with liver disease because clearance is slowed. Severe liver insufficiency is a formal contraindication for use, and regulatory documents indicate that caution is necessary for patients with any degree of liver impairment.


Q: What is the shelf life of Diaston?

A: Official drug packaging and regulatory stability studies provide the labeled expiration date, which indicates the shelf life. The medicine must be kept in its original packaging at controlled room temperature and protected from freezing or excessive heat to maintain its stability.


Q: Are there any known issues with taking Diaston before surgery?

A: Because Diaston is a Central Nervous System (CNS) depressant, there is a potential for additive effects if it is combined with other CNS depressants, such as anesthetics or pain medications used during or after a surgical procedure. This combination increases the risk of excessive sedation and breathing difficulties.


Q: What is the expected long-term outcome for people on Diaston?

A: As Diaston is an acute rescue treatment, its role is limited to the immediate management of seizure episodes. Regulatory documents note that the expected long-term outcomes related to the overall seizure condition are not fully established, and follow-up studies were limited to monitoring safety patterns over intermittent use periods.

How should Diaston be stored and disposed of?

Official Storage and Disposal Requirements

Regulatory documentation mandates that Diaston be stored at controlled room temperature, typically between 20 C and 25 C. The product must be kept in its original, tightly closed container and protected from both excessive moisture and intense light. To maintain stability, the medicine must not be frozen or exposed to temperatures above the labeled maximum.

All packaging must be kept out of the sight and reach of children using child-resistant mechanisms if applicable. For disposal, unused or expired Diaston should not be discarded in household trash or poured down a sink or toilet. Official instructions require returning the product to an authorized drug take-back location or following specific governmental guidance for safe, environmentally sound disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diaston found in:

A-Z Index: